Skip to content
Review

From Data to Early Diagnosis: Artificial Intelligence as a Tool to Support Screening and Detection of Autism Spectrum Disorder in Childhood

Jul 2026 · Current Psychiatry Reports · Vol 28 · 0 citations · 42 references
Medicine

TL;DR

Artificial intelligence shows promise as a supportive tool for early screening, but current evidence supports its use as a complement to, rather than replacement for, clinical assessment.

View source

Similar papers

Conference Jul 2026

Advanced Computational Approaches for Early detection of Autism Spectrum Disorder using Machine and Deep Learning: Recent Trends and Perspective

Autism Spectrum Disorder (ASD) is a neurological and developmental condition characterized by challenges in social interaction, communication (both verbal and non-verbal), and repetitive behaviours. While genetics play a key role in its onset, early diagnosis remains essential for effective intervention. Machine learning (ML) offers a promising approach to streamline and accelerate ASD detection, making it faster and more cost-effective than traditional methods. This paper evaluates eight classification models to identify key ASD features and automate diagnosis. We compare their performance on large datasets to enhance predictive accuracy. ML has transformed healthcare by leveraging vast data volumes for analysis, with technological advances over the past decade improving diagnostic tools now standard in medical settings. ASD affects individuals variably, with symptoms typically appearing between 18 months and 3 years. Although genetic and environmental factors contribute, no single cause is confirmed. Traditional screenings rely heavily on clinician expertise, involving manual assessments and scoring, which can be subjective and time-consuming—even experts face uncertainties in predicting onset or severity. Parents seek rapid, reliable results. ML and deep learning (DL) address these gaps by analyzing complex patterns in data, enabling early prediction of ASD and its severity. This study implements diverse algorithms to support precise, automated screening, reducing diagnostic delays and improving outcomes.

Devireddy Mamatha, K. Maheswari · 0 citations
#explainable ai Review Aug 2026

AI and neuroimaging in autism spectrum disorder: advances in diagnosis, methodological challenges and future directions

A comprehensive review of recent advancements in ASD research, with particular emphasis on neuroimaging, artificial intelligence (AI), and machine learning (ML)-based diagnostic approaches, highlights the growing potential of AI-driven tools for supporting early ASD diagnosis and emphasizes the need for standardized protocols, external validation, explainable AI, and clinically translatable frameworks.

Kuljeet Singh, Khushi Mogha, S. Moctar · 0 citations
Review Jul 2026

Emerging Approaches for Early Diagnosis of Autism: A Comprehensive Survey of Machine, Deep and Transfer Learning Methods

Based on the evaluated studies, transfer learning with diverse datasets and modalities has great promise for early ASD diagnosis, and a hybrid transfer learning-based framework is advised to assist clinicians and therapists in accurately diagnosing and assessing ASD severity.

R. Thillaikarasi, P. Kumaresan · 0 citations
Review Open access Jun 2026

Artificial intelligence, equity, and pediatric neurodevelopmental disorders: A scoping review of clinical practice applications

AI shows promise for pediatric NDD care, but equitable clinical adoption will require inclusive research, external validation, and equity‐focused implementation, with particular attention to equity considerations.

Florida Uzoaru, O. Oleribe, U. Nwaozuru et al. · 0 citations
Review Open access Jul 2026

Artificial intelligence, autism care, and health equity: a public health narrative review

It is argued that AI’s most important contribution to autism care is unlikely to lie in marginal improvements in classification accuracy alone, and its potential value lies in expanding access, supporting task-sharing, shortening diagnostic pathways, enabling population-oriented screening, and reaching under-recognised groups.

Xugao Han, Lingyan Weng, Houxi Xu · 0 citations